HSV-2 Infection
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes
Immunogenetic Modulators of Mucosal Protection From HIV-1
The VIBLOK SAfety and perFormancE Trial
The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya
Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa
Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation